CAMG
TEVA icon

CWA Asset Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

CWA Asset Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-151,537
Closed -$3.34M – 627
2024
Q4 		$3.34M Buy
+151,537
New +$2.76M 0.17% 120
2019
Q1 		– Sell
-26,425
Closed -$407K – 232
2018
Q4 		$407K Buy
26,425
+3,140
+13% +$64.4K 0.09% 124
2018
Q3 		$502K Buy
23,285
+1,129
+5% +$26.2K 0.11% 115
2018
Q2 		$539K Buy
+22,156
New +$452K 0.13% 115

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

CWA Asset Management Group's TEVA Position: Q1 2025 in Review

CWA Asset Management Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 151,537 shares — an estimated $3.34M sold.

CWA Asset Management Group first reported a position in TEVA in Q2 2018 and held it in 4 quarters. The position peaked at $3.34M in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • CWA Asset Management Group reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • CWA Asset Management Group sold 151,537 Teva Pharmaceuticals shares in Q1 2025, an estimated $3.34M.
  • CWA Asset Management Group first reported a position in Teva Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • CWA Asset Management Group's Teva Pharmaceuticals position peaked at $3.34M in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on CWA Asset Management Group's 13F filing for Q1 2025, filed 21 Apr 2025.